Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Merck
Fuji
Chinese Patent Office
Farmers Insurance
Dow
Teva
Chubb
Johnson and Johnson
Queensland Health

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,895,726

« Back to Dashboard

Summary for Patent: 4,895,726
Title: Novel dosage form of fenofibrate
Abstract:The present invention relates to a novel dosage form of fenofibrate containing fenofibrate and a solid surfactant which have been co-micronized. It also relates to the method for the preparation of this dosage form and its use for improving the bioavailabity in vivo.
Inventor(s): Curtet; Bernard (Marsanny la Cote, FR), Teillaud; Eric (Talant, FR), Reginault; Philippe (Fontaine les Dijon, FR)
Assignee: Fournier Innovation et Synergie (Paris, FR)
Application Number:07/299,073
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form; Formulation;

Drugs Protected by US Patent 4,895,726

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,895,726

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France88 02359Feb 26, 1988

International Patents Family Members for US Patent 4,895,726

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 83374 ➤ Subscribe
Australia 2982889 ➤ Subscribe
Australia 614577 ➤ Subscribe
Canada 1322529 ➤ Subscribe
Germany 68903846 ➤ Subscribe
European Patent Office 0330532 ➤ Subscribe
Spain 2054040 ➤ Subscribe
France 2627696 ➤ Subscribe
Greece 3006798 ➤ Subscribe
Japan H01254624 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Farmers Insurance
McKesson
Accenture
Medtronic
Merck
Chinese Patent Office
UBS
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot